ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.20, $0.01 better than the analyst estimate of $1.19. Revenue for the quarter came in at $95.7 million versus the consensus estimate of $94.43 million.

GUIDANCE:

ICU Medical sees FY2017 EPS of $3.55-$3.90, versus the consensus of $3.97. ICU Medical sees FY2017 revenue of $1.2-1.25 million, versus the consensus of $1.31 million.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.